Financial News

Financial Report: West

Contract-Manufactured Products sales up 10% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

West

1Q Revenues: $387.7 million (+7%)

1Q Earnings: $60.9 million (earnings were $22.1 million 1Q16)

Comments: Proprietary Products segment sales were $308.8 million, up 6%. Contract-Manufactured Products segment sales were $79.1 million, up 10%. Restructuring and related charges in 1Q16 were $22.9 million, consisting of $7.9 million for severance charges and $15.0 million for non-cash asset write-downs associated with the discontinued use of certain trademarks and equipment.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters